Sumukh Arun Kumar

Sumukh Arun Kumar

Auto-generated profile, based on publicly available information

Sumukh Arun Kumar

Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2023 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
PKPramukh Arun Kumar
Pramukh Arun Kumar
BPBoskey Patel
Boskey Patel
MDMahati Dasari
Mahati Dasari
SKSumukh Arun Kumar
Sumukh Arun Kumar
NSNeeta Shah
Neeta Shah
DLDouglas Laidlaw
Douglas Laidlaw
Background: Infective endocarditis can progress to an intracardiac abscess in 20% to 30% of cases, with interventricular septal abscess (IVSA) being one of the rare complications usually presenting with sepsis. We present a case of IVSA presenting with a new-onset second-degree heart block, which rapidly progressed to a complete heart block. Case presentation: A 80-year-old Caucasian female with a past medical history of hypertension and hyperlipidemia presented with exertional chest pain, lightheadedness, and shortness of breath with telemetry and electrocardiogram revealing persistent Mobitz type II second degree atrioventricular block. The rest of the vitals were normal. As she was being planned for a pacemaker placement, she spiked a temperature of 103F. Blood cultures grew methicillin-sensitive Staphylococcus aureus, and appropriate antibiotics were initiated. Transthoracic echocardiogram was grossly normal. However, transesophageal echocardiogram revealed a heterogeneous extension of an echodensity from the aortic root, along the aorto-mitral cushion and into the interventricular septum, indicating an interventricular septal abscess. Her course was complicated by altered mental status, with computed tomography of the brain revealing hypodense regions in the left lentiform nucleus and anterior caudate nucleus representing acute/subacute stroke. Surgery was deferred as she was deemed a poor candidate. She succumbed to her illness on day 6 of hospitalization. Conclusion: Intracardiac abscesses should be considered a possible initial differential in patients with progressive heart block despite aseptic presentation and no risk factors.

13 June 2023 in Hematological Oncology
Verified
Journal Article
Open access
RMRahul Mishra
Rahul Mishra
DDDanai Dima
Danai Dima
SKSumukh A. Kumar
Sumukh A. Kumar
AMAgrima Mian
Agrima Mian
ATAlankrita Taneja
Alankrita Taneja
DJDeepa Jagadeesh
Deepa Jagadeesh
With improvement in survival after chronic lymphocytic leukemia (CLL) diagnosis, the real-world burden of second hematological malignancies (SHM) has not been comprehensively assessed in recent era. We analyzed risk, incidence, and outcomes of SHM in CLL patients between 2000 and 2019 using SEER database. CLL patients had greater risk for hematological malignancies than general population [SIR, standardized incidence ratio (95% CI):2.58 (2.46-2.70); p < 0.05]. The risk for subsequent lymphoma increased by 1.75 folds in 2015-2019 compared to 2000-2004. The duration, after CLL diagnosis, of maximum risk for SHM decreased as 60-119 months for time-period 2000-2004, 6-11 months for 2005-2009 to 2-5 months for 2010-2014 and 2015-2019. Incidence of SHM was 2.5% in CLL survivors (1736/70,346) with lymphoid SHM being more common than myeloid SHM, and DLBCL being the most common pathology (n = 610, 35% of all SHM). Male sex, age <= 65 years at CLL diagnosis, and chemotherapy treatment were associated with higher risk for SHM. The median gap between CLL and SHM diagnoses was 46 months. The median survival for de-novo-AML, t-MN, CML, and aggressive NHL was 63, 86, 95, and 96 months respectively. Although SHM remains rare, there is increased risk in recent era, likely due to improved survival in CLL patients, necessitating active surveillance strategies.

4 May 2023 in Cureus
Verified
Journal Article
Open access
PDF file
SKSumukh Arun Kumar
Sumukh Arun Kumar
Chidambaram RamasamyChidambaram Ramasamy
Chidambaram Ramasamy
MSMasood Pasha Syed
Masood Pasha Syed
AAArchana Agarwal
Archana Agarwal
Splenic masses could be secondary to infection or due to benign and malignant cancers. Due to its anatomy and microenvironment, the spleen is relatively protected from cancer spread. However, melanomas are one of the few cancers that metastasize to the spleen, but only 2% of these metastasize as solitary splenic masses. Among such a small fraction, only a handful have been reported without a known primary. Our patient, an elderly male in his early 60s, was diagnosed with metastatic melanoma of the spleen following a biopsy of the incidentally detected isolated splenic mass. Complete ocular, oral, and dermatological inspections were unremarkable for a probable primary. He responded well to immunotherapy and total splenectomy with no recurrence. Due to advanced imaging modalities in the modern era, the probability of isolated splenic masses as an initial presentation will increase, and a high index of clinical suspicion should be maintained for metastatic cancer as one of the differentials.

26 December 2023 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
SKSumukh Arun Kumar
Sumukh Arun Kumar
RMRahul Mishra
Rahul Mishra
SMSarat Chandra Malempati
Sarat Chandra Malempati
PBPoorva Bindal
Poorva Bindal
A female patient in her mid-60s presented with progressive shortness of breath, pleuritic chest pain and bilateral leg swelling for 1 week. Initial diagnostic workup revealed pericardial effusion, and a localised pericardial tubular mass on CT chest. Pericardial fluid analysis showed elevated white cells, with predominance of medium-large sized atypical lymphoid cells. Atypical lymphocytes stained positive for CD79a, CD10, PAX-5, BCL-2 and BCL6. Fluorescence in situ hybridisation testing demonstrated MYC and BCL6 rearrangements without BCL2 gene rearrangement. The overall morphological, immunohistochemical and cytogenetic findings supported a diagnosis of high-grade B cell lymphoma with MYC and BCL6 rearrangements. After extensive staging workup, localised disease involving the pericardium with a diagnosis of primary cardiac large B cell lymphoma was established. She was treated with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab chemotherapy. Rituximab was discontinued owing to largely absent CD20 expression. Interim positron emission tomography-CT after three cycles revealed a complete response, and the patient completed six cycles of therapy.

1 May 2023
Verified
Conference Paper
Closed access
SPS. Prabhu
S. Prabhu
HGH. Shanmugavel Geetha
H. Shanmugavel Geetha
SKS. Arun Kumar
S. Arun Kumar
MGM.V. Gogtay
M.V. Gogtay
SGS.V. George
S.V. George
SSS. Scott
S. Scott

1 June 2024 in Annals of Internal Medicine: Clinical Cases
Verified
Journal Article
Closed access
SKSumukh Arun Kumar
Sumukh Arun Kumar
KBKannu Bansal
Kannu Bansal
CRChidambaram Ramasamy
Chidambaram Ramasamy
SPSushmita Prabhu
Sushmita Prabhu
GAGeorge M. Abraham
George M. Abraham